Sophis adds credit derivatives pricing to risk platform

Sophis, a risk management technology vendor based in Paris, has enhanced its 'Risque 'portfolio and risk management system with added credit derivatives pricing and risk management capabilities.

The latest release incorporates a new pricing model for credit default swaps (CDS)- the 'bootstrap' model. This model inverts the CDS rate curve to obtain the term structure of default probability. It also includes historical and stress-testing value-at-risk calculations for CDS, and credit risk multi-currency management, which enables it to measure risk for companies and their subsidiary entities.

The credit default swaps module also offers multi-currency credit curves. Risque users can shock CDS rates, default probabilities or recovery rates, and output results as sensitivities or hedge notional credit derivatives.

Sophis said a number of its clients are already using the CDS module, but declined to name them.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Chartis RiskTech100® 2024

The latest iteration of the Chartis RiskTech100®, a comprehensive independent study of the world’s major players in risk and compliance technology, is acknowledged as the go-to for clear, accurate analysis of the risk technology marketplace. With its…

T+1: complacency before the storm?

This paper, created by WatersTechnology in association with Gresham Technologies, outlines what the move to T+1 (next-day settlement) of broker/dealer-executed trades in the US and Canadian markets means for buy-side and sell-side firms

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here